Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 5 | 0 | 700,30 € | 755,83 € | 7,93 % |
| Vertex Pharmaceuticals Inc. | 39 | 2 | 4 | 0 | 369,65 € | 382,71 € | 3,53 % |
| Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | 839,60 € | 954,29 € | 13,66 % |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | 117,60 € | 124,92 € | 6,22 % |
| Trinity Biotech ADR | 24 | 0 | 3 | 0 | 0,41 € | - | - |
| Amgen Inc. | 23 | 0 | 3 | 0 | 246,85 € | 293,65 € | 18,96 % |
| Cytokinetics Inc. | 24 | 1 | 4 | 0 | 63,00 € | 88,82 € | 40,99 % |
| Intra-Cellular Therapies Inc. | 21 | 0 | 5 | 0 | 67,50 € | 77,61 € | 14,98 % |
| Neurocrine Bioscience | 21 | 0 | 3 | 0 | 124,50 € | 137,10 € | 10,12 % |
| Sutro Biopharma Inc | 18 | 0 | 7 | 0 | 3,50 € | 11,05 € | 215,67 % |
| BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | 84,64 € | 102,48 € | 21,07 % |
| Natural Alternat. | 19 | 1 | 2 | 0 | 6,00 € | - | - |
| AbbVie Inc. | 18 | 1 | 3 | 1 | 154,72 € | 175,79 € | 13,62 % |
| Novo Nordisk A/S ADR | 17 | 1 | 5 | 0 | 115,50 € | 130,00 € | 12,55 % |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | 11,01 € | 22,78 € | 106,95 % |
| Abbott Laboratories | 17 | 1 | 2 | 0 | 98,91 € | 116,71 € | 18,00 % |
| United Therapeutics | 15 | 0 | 0 | 0 | 222,50 € | 289,92 € | 30,30 % |
| Exelixis Inc. | 15 | 0 | 0 | 0 | 21,44 € | 26,01 € | 21,30 % |
| TG Therapeutics Inc. | 19 | 4 | 3 | 0 | 13,15 € | 26,00 € | 97,70 % |
| Icon plc | 15 | 0 | 3 | 0 | 274,10 € | 318,32 € | 16,13 % |
| Krystal Biotech | 15 | 0 | 2 | 0 | 154,00 € | 166,84 € | 8,34 % |
| EyePoint Pharmaceuticals Inc. | 15 | 1 | 0 | 1 | 16,45 € | 28,17 € | 71,23 % |
| Stoke Therapeutics Inc | 15 | 1 | 7 | 1 | 11,00 € | 21,39 € | 94,48 % |
| G1 Therapeutics | 14 | 1 | 2 | 0 | 3,83 € | 10,56 € | 175,84 % |
| Acorda Therapeutics Cdt | 13 | 0 | 0 | 0 | 0,47 € | - | - |